Covaxin phase 3 trial data is finally peer reviewed. The prestigious medical journal Lancet has found the vaccine to be 77.8% effective against symptomatic COVID-19 and 65.2% effective against the delta strain. Also Delhi air pollution is back in the severe category, with wind speeds in single digits, local pollutants are being trapped and mixed with emissions from farm fires.
